XL019 Terminated Phase 1 Trials for Polycythemia Vera (PV) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00595829A Phase 1 Study of XL019 in Adults With Polycythemia Vera